Review of the epidemiology and burden of ulcerative colitis in Latin America

por Kotze, Paulo Gustavo, Steinwurz, Flavio, Francisconi, Carlos, Zaltman, Cyrla, Pinheiro, Marcia, Salese, Leonardo, Ponce de Leon, Dario
Publicado 2020

Tofacitinib as a maintenance therapy in patients with ulcerative colitis stratified by OCTAVE Sustain baseline Mayo endoscopic subscore

por Lee, Scott D., Allegretti, Jessica R., Steinwurz, Flavio, Connelly, Susan B., Lawendy, Nervin, Paulissen, Jerome, Gecse, Krisztina B.
Publicado 2023

Inflammatory bowel disease activity assessed by fecal calprotectin and lactoferrin: correlation with laboratory parameters, clinical, endoscopic and histological indexes

por Vieira, Andrea, Fang, Chia Bin, Rolim, Ernani Geraldo, Klug, Wilmar Artur, Steinwurz, Flávio, Rossini, Lucio Giovanni Battista, Candelária, Paulo Azevedo
Publicado 2009

Disease Activity and Health-related Quality of Life Relationships with Work Productivity in Patients with Ulcerative Colitis in OCTAVE Induction 1 and 2 and OCTAVE Sustain

por Targownik, Laura, Dubinsky, Marla C, Steinwurz, Flavio, Bushmakin, Andrew G, Cappelleri, Joseph C, Tai, Elaine, Gardiner, Sean, Hur, Peter, Panés, Julian
Publicado 2022

Corticosteroid-free efficacy and safety outcomes in patients receiving tofacitinib in the OCTAVE Sustain maintenance study

por Vavricka, Stephan R., Greuter, Thomas, Cohen, Benjamin L., Reinisch, Walter, Steinwurz, Flavio, Fellmann, Marc, Guo, Xiang, Lawendy, Nervin, Paulissen, Jerome, Peyrin-Biroulet, Laurent
Publicado 2022

Association of C-reactive Protein and Partial Mayo Score With Response to Tofacitinib Induction Therapy: Results From the Ulcerative Colitis Clinical Program

por Dubinsky, Marla C, Magro, Fernando, Steinwurz, Flavio, Hudesman, David P, Kinnucan, Jami A, Ungaro, Ryan C, Neurath, Markus F, Kulisek, Nicole, Paulissen, Jerome, Su, Chinyu, Ponce de Leon, Dario, Regueiro, Miguel
Publicado 2022

COVID-19 Outcomes Among Racial and Ethnic Minority Individuals With Inflammatory Bowel Disease in the United States

por Agrawal, Manasi, Brenner, Erica J., Yan Mak, Joyce Wing, Zhang, Xian, Kaplan, Gilaad G., Ng, Siew C., Reinisch, Walter, Steinwurz, Flavio, Lewis, James D., Kissous-Hunt, Michele, Modesto, Irene, Ungaro, Ryan C., Colombel, Jean-Frederic, Kappelman, Michael D.
Publicado 2021

Worldwide Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: An International Survey

por Bernstein, Charles N, Ng, Siew C, Banerjee, Rupa, Steinwurz, Flavio, Shen, Bo, Carbonnel, Franck, Hamid, Saeed, Sood, Ajit, Yamamoto-Furusho, Jesus K, Griffiths, Anne, Benchimol, Eric I, Travis, Simon, Lopes, Susana, Rubin, David T, Kaplan, Gilaad G, Armstrong, David, Gearry, Richard
Publicado 2020

Sa502 THE FIRST AND SECOND WAVE OF COVID-19 IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A TEMPORAL TREND ANALYSIS

por Kaplan, Gilaad, Underwood, Fox E., Tanyingoh, Divine, Agrawal, Manasi, Ungaro, Ryan C., Brenner, Erica J., Gearry, Richard, Kissous-Hunt, Michele, Lewis, James D., Ng, Siew C., Rahier, Jean-Francois, Reinisch, Walter, Steinwurz, Flavio, Zhang, Xian, Kappelman, Michael, Colombel, Jean Frederic
Publicado 2021

Combination of corticosteroids and 5-aminosalicylates or corticosteroids alone for patients with moderate-severe active ulcerative colitis: A global survey of physicians' practice

por Ben-Horin, Shomron, Andrews, Jane M, Katsanos, Konstantinos H, Rieder, Florian, Steinwurz, Flavio, Karmiris, Konstantinos, Cheon, Jae Hee, Moran, Gordon William, Cesarini, Monica, Stone, Christian D, Schwartz, Doron, Protic, Marijana, Roblin, Xavier, Roda, Giulia, Chen, Min-Hu, Har-Noy, Ofir, Bernstein, Charles N
Publicado 2017

Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry

por Brenner, Erica J., Ungaro, Ryan C., Gearry, Richard B., Kaplan, Gilaad G., Kissous-Hunt, Michele, Lewis, James D., Ng, Siew C., Rahier, Jean-Francois, Reinisch, Walter, Ruemmele, Frank M., Steinwurz, Flavio, Underwood, Fox E., Zhang, Xian, Colombel, Jean-Frederic, Kappelman, Michael D.
Publicado 2020

The Multiple Waves of COVID-19 in Patients With Inflammatory Bowel Disease: A Temporal Trend Analysis

por Kaplan, Gilaad G, Underwood, Fox E, Coward, Stephanie, Agrawal, Manasi, Ungaro, Ryan C, Brenner, Erica J, Gearry, Richard B, Kissous-Hunt, Michele, Lewis, James D, Ng, Siew C, Rahier, Jean-Francois, Reinisch, Walter, Steinwurz, Flavio, Zhang, Xian, Kappelman, Michael D, Colombel, Jean-Frederic
Publicado 2022

Physician Practice Patterns in Holding Inflammatory Bowel Disease Medications due to COVID-19, in the SECURE-IBD Registry

por Agrawal, Manasi, Brenner, Erica J, Zhang, Xian, Colombel, Jean-Frederic, Kappelman, Michael D, Ungaro, Ryan C, Gearry, Richard B, Kalpan, Gilaad G, Kissous-Hunt, Michele, Lewis, James D, Ng, Siew C, Rahier, Jean-Francois, Reinisch, Walter, Ruemmele, Frank M, Steinwurz, Flavio, Underwood, Fox E
Publicado 2020

Biologic Agents in Crohn's Patients Reduce CD4(+) T Cells Activation and Are Inversely Related to Treg Cells

por Rosseto-Welter, Eliane Aparecida, D'argenio-Garcia, Leticia, Blasco Tavares Pereira Lopes, Filipa, Zulim Carvalho, Ana Eduarda, Flaquer, Fernando, Severo-Lemos, Vanessa, Viero Nora, Claudia Concer, Steinwurz, Flavio, Pires Garcia Oliveria, Lucas, Aloia, Thiago, Rizzo, Luiz Vicente, Pitangueira Mangueira, Cristóvão Luis, Carvalho, Karina Inacio
Publicado 2022

Effectiveness and Safety of Tofacitinib in the Management of Ulcerative Colitis: A Brazilian Observational Multicentric Study

por Perin, Ramir Luan, Magro, Daniela Oliveira, Andrade, Adriana Ribas, Argollo, Marjorie, Carvalho, Nayara Salgado, Damião, Adérson Omar Moura Cintra, Dotti, Adriana Zanoni, Ferreira, Sandro da Costa, Flores, Cristina, Ludvig, Juliano Coelho, Nones, Rodrigo Bremer, Queiroz, Natalia Sousa Freitas, Parra, Rogério Serafim, Steinwurz, Flavio, Teixeira, Fabio Vieira, Kotze, Paulo Gustavo
Publicado 2022

Vedolizumab in Mild-to-Moderate Crohn’s Disease Patients Naïve to Biological Therapy: A Multicentric Observational Study

por Dotti, Adriana Zanoni, Magro, Daniela Oliveira, Vilela, Eduardo Garcia, Chebli, Julio Maria Fonseca, Chebli, Liliana Andrade, Steinwurz, Flavio, Argollo, Marjorie, Carvalho, Nayara Salgado, Parente, Jose Miguel Luz, Lima, Murilo Moura, Parra, Rogério Serafim, Perin, Ramir Luan, Flores, Cristina, Morsoletto, Eloá Marussi, da Costa Ferreira, Sandro, Ludvig, Juliano Coelho, Kaiser Junior, Roberto Luiz, Faria, Mikaell Alexandre Gouvea, Nicollelli, Guilherme Mattioli, Andrade, Adriana Ribas, Queiroz, Natalia Sousa Freitas, Kotze, Paulo Gustavo
Publicado 2023

Long-term effectiveness and safety of ustekinumab in bio-naïve and bio-experienced anti-tumor necrosis factor patients with Crohn’s disease: a real-world multicenter Brazilian stud...

por Parra, Rogério Serafim, Chebli, Júlio Maria Fonseca, Queiroz, Natália Sousa Freitas, Damião, Aderson Omar Mourão Cintra, de Azevedo, Matheus Freitas Cardoso, Chebli, Liliana Andrade, Bertges, Erika Ruback, Alves Junior, Antonio José Tiburcio, Ambrogini Junior, Orlando, da Silva, Bianca Loyo Pona Schiavetti, Lubini, Marcio, Bafutto, Mauro, Flores, Cristina, Vilela, Eduardo Garcia, Boratto, Sandra Felice, Gasparetti Junior, Newton Luiz Tricarico, Steinwurz, Flavio, Carvalho, Nayara Salgado, Féres, Omar, da Rocha, José Joaquim Ribeiro
Publicado 2022